Technology | 2019.10.11
Glauconix Biosciences Announces Appointment of Robert Dempsey to Board of Directors
ALBANY, N.Y., Oct. 11, 2019 /PRNewswire/ -- Glauconix Biosciences, Inc., a specialty pharmaceutical company that uses its patented platform technology to develop human 3D ocular tissues that mimic the fluid dynamics in the eye to expedite and de-risk the R&D of ophthalmic treatments,...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]rd-of-directors-300937226.html
